Skip to main content

Supraventricular Tachycardia clinical trials at UCSF

1 research study open to eligible people

Supraventricular tachycardia is a fast heart rate starting in the upper heart chambers. UCSF is studying unborn babies with a new diagnosis of this heart rate issue. This study is called the 'Fetal Atrial Flutter & Supraventricular Tachycardia' trial.

Showing trials for
  • Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia

    open to eligible females ages 16-50

    The FAST Trial Registry is a prospective observational cohort study of fetuses with a new diagnosis of atrial flutter (AF) or supraventricular tachycardia (SVT) that is severe enough to consider prenatal treatment (see eligibility criteria below). Aims of the Registry include to establish a large clinical database to determine and compare the efficacy and safety of different prenatal treatment strategies including observation without immediate treatment, transplacental antiarrhythmic fetal treatment and direct fetal treatment from the time of tachycardia diagnosis to death, neonatal hospital discharge or to a maximum of 30 days after birth.

    San Francisco, California and other locations

Last updated: